Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
Pfizer Stock (PFE) Slips as U.S. Probes the Timing of Its COVID-19 Vaccine Results
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...
Fierce Pharma20h
GSK tip claiming Pfizer delayed COVID vaccine results during 2020 election prompts US probe: WSJ
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...
Pfizer: Undervalued Defensive Play
With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...
The Trump Administration Threatens mRNA Research
What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...
U.S. prosecutors look into claim Pfizer delayed vaccine news, WSJ says
U.S. prosecutors are looking into a claim that GSK (GSK) scientist, who formerly worked at Pfizer (PFE), told colleagues that Pfizer delayed ...
Scientific American10d
Lifesaving mRNA Vaccine Technology Appears Targeted under Trump and RFK, Jr.
Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway ...
Medscape3d
Bivalent RSV Vaccine Shows Sustained Efficacy and Safety Through Two Seasons in Older Adults
The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...